(V019) Flowire
Total Payments
$30,000
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $30,000 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $30,000 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Intracoronary Acetylcholine Stability: Overcoming Barriers to Coronary Vasospasm Testing Programs | Philips Electronics North America Corporation | $30,000 | 0 |
Top Doctors Receiving Payments for (V019) Flowire
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $30,000 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $30,000
- Total Doctors 0
- Transactions 1
About (V019) Flowire
(V019) Flowire is a device associated with $30,000 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Philips Electronics North America Corporation.
Payment data is available from 2023 to 2023. In 2023, $30,000 was paid across 1 transactions to 0 doctors.
The most common payment nature for (V019) Flowire is "Unspecified" ($30,000, 100.0% of total).
(V019) Flowire is associated with 1 research study, including "Intracoronary Acetylcholine Stability: Overcoming Barriers to Coronary Vasospasm Testing Programs" ($30,000).